Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GoodRx HoldingsGDRX +0.15%69 3-1 Month Momentum % is 11.70% as of Aug. 25, 2026. GuruFocus rates GDRX with a GF Score™ of 69/100 and a GF Value™ of $5.28 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 665 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 80.45% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-25), GoodRx Holdings's 3-1 Month Momentum % is 11.70%.
The industry rank for GoodRx Holdings's 3-1 Month Momentum % or its related term are showing as below:
GDRX's 3-1 Month Momentum % is ranked better than 80.45% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: -2.08
vs GDRX: 11.70
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
GoodRx Holdings 3-1 Month Momentum % Related Terms
GDRX vs SDGR, TALK, CERT: 3-1 Month Momentum % Comparison
For the Health Information Services subindustry, GoodRx Holdings's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GoodRx Holdings 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GoodRx Holdings (GDRX) has a 3-1 Month Momentum % of 11.70% as of Aug. 25, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on GoodRx Holdings and its competitors. According to the industry distribution chart, GoodRx Holdings ranks #130 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 19.5%.
Is GoodRx Holdings' 3-1 Month Momentum % too high?
GoodRx Holdings' current 3-1 Month Momentum % is 11.70%. Based on the distribution chart, GoodRx Holdings ranks #130 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, GoodRx Holdings has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' 3-1 Month Momentum % compare to SDGR and TALK?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #130 out of 665 companies for 3-1 Month Momentum %. This places GoodRx Holdings in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on GoodRx Holdings and its competitors. GoodRx Holdings's current 3-1 Month Momentum % is 11.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.28, compared to a current price of $3.45 — trading 34.7% below its estimated fair value. The current 3-1 Month Momentum % is 11.70%. GoodRx Holdings' overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current 3-1 Month Momentum % is 11.70% as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GoodRx Holdings (GDRX) Overvalued in 2026?
Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued.
The current stock price of $3.45 is trading 34.7% below its estimated GF Value™ of $5.28.
GuruFocus considers GoodRx Holdings to be Possible Value Trap.
Key valuation signals for GDRX:
3-1 Month Momentum %: 11.70%
GF Value™: $5.28 vs. price of $3.45 (34.7% below fair value)
No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
69GF Score
Get the complete analysis for GDRX
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GDRX has been successfully added to your 
